LEVBIO logo

Level Bio AB (publ) Stock Price

NGM:LEVBIO Community·SEK 23.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

LEVBIO Share Price Performance

SEK 0.34
0.05 (16.44%)
SEK 0.34
0.05 (16.44%)
Price SEK 0.34

LEVBIO Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks
0 Rewards

Level Bio AB (publ) Key Details

SEK 30.4m

Revenue

SEK 14.1m

Cost of Revenue

SEK 16.3m

Gross Profit

SEK 20.1m

Other Expenses

-SEK 3.8m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.056
53.64%
-12.55%
0%
View Full Analysis

About LEVBIO

Founded
1998
Employees
10
CEO
Joakim Granemo
WebsiteView website
levelbio.se

Level Bio AB (publ) manufactures and distributes cutting-edge and diagnostic solutions in the Nordic region and internationally. It develops and manufactures diagnostic kits for the clinical market, as well as act as a distributor and full service partner to molecular biology labs in the Nordics. The company was formerly known as AlphaHelix Molecular Diagnostics AB (publ) and changed its name to Level Bio AB (publ) in May 2024. Level Bio AB (publ) was incorporated in 1998 and is headquartered in Stockholm, Sweden.

Recent LEVBIO News & Updates

Recent updates

No updates